CVST/CVT is an emergency diagnosis, not a routine travel diagnosis
A new severe or unusual headache, seizure, weakness, speech or visual disturbance, confusion, reduced consciousness or signs of raised intracranial pressure require urgent local assessment. The disease can worsen rapidly because impaired venous drainage may cause venous infarction, brain swelling and intracranial haemorrhage. International consultation is most appropriate after the acute event is stabilized or when reviewing a complex diagnosis, cause or long-term anticoagulation plan.
Confirm thrombosis with venous imaging
The German S2k guideline considers CT with CT venography and MRI with MR venography equivalent for diagnosing sinus thrombosis. MRI is superior for isolated cortical-vein thrombosis and avoids radiation, so it is preferred in younger patients and during pregnancy when clinically feasible. Catheter DSA is rarely needed purely for diagnosis when non-invasive venous imaging is conclusive.
A normal D-dimer does not routinely rule out CVT
The current German guideline advises against routine use of D-dimer to exclude cerebral venous thrombosis. A negative result may be informative only in selected low-probability patients with isolated headache, no neurological symptoms and a relatively short symptom duration. When clinical suspicion is meaningful, appropriate venous imaging should not be delayed because a blood test is normal.
Therapeutic heparin is standard acute treatment
The German S2k guideline recommends therapeutic-dose heparin during the acute phase regardless of whether an intracranial haemorrhage is already visible. This differs from many intuitive assumptions about anticoagulation after a brain bleed because the haemorrhage in CVT can result from venous congestion. Low-molecular-weight heparin is generally preferred over unfractionated heparin, while unfractionated heparin may be favored when an operation or endovascular procedure is expected or when LMWH is unsuitable.
Raised intracranial pressure changes the level of care
Patients with neurological deterioration, large venous infarction, mass effect, reduced consciousness or other signs of increasing intracranial pressure need treatment in a center capable of neurocritical care, interventional neuroradiology and neurosurgery. The German guideline recommends transfer to such a center at the latest when intracranial-pressure signs emerge.
Mechanical thrombectomy or recanalization is a rescue option for selected severe cases
Endovascular treatment should not be presented as routine first-line therapy. The German guideline states that individual patients who deteriorate despite adequate anticoagulation may be considered for endovascular recanalization in a neurointerventional center. Heidelberg University Hospital explicitly offers catheter-based mechanical reopening of severe sinus or cerebral-vein thrombosis using stent retrievers, aspiration and selected adjunctive techniques.
Decompressive neurosurgery may be lifesaving in malignant swelling
When large venous infarction or haemorrhage causes life-threatening mass effect and impending herniation, decompressive surgery can become an emergency treatment question. This decision is separate from anticoagulation and thrombectomy and requires a center with immediate neurosurgical and neurocritical-care capability.
After stabilization, oral anticoagulation is continued for a risk-based period
The German guideline recommends at least three months of anticoagulation and generally frames maintenance treatment within roughly three to twelve months for patients with low recurrence risk. Treatment should not be prolonged solely to force further radiological recanalization. Longer secondary prophylaxis can be appropriate when persistent factors such as active malignancy, severe thrombophilia or another ongoing prothrombotic condition raise recurrent venous-thromboembolism risk.
DOACs are generally favored in the maintenance phase, with important exceptions
After the acute phase, the German guideline favors direct oral anticoagulants over vitamin-K antagonists for many adult patients because available evidence supports comparable efficacy with a favorable safety profile. Important exceptions exist, including patients with triple-positive antiphospholipid syndrome, where vitamin-K antagonist therapy is generally preferred. Choice and dosing remain individual clinical decisions.
Do not order broad thrombophilia testing automatically
Routine thrombophilia screening for every CVT patient is not recommended. Testing can be considered when the result could change treatment, particularly in younger patients, spontaneous or recurrent CVT, or a positive family history of venous thromboembolism. Timing matters because acute thrombosis, pregnancy and anticoagulant medication can distort some laboratory results.
Pregnancy, postpartum state and estrogen exposure matter
CVT has specific implications for contraception, pregnancy and the postpartum period. The German guideline provides recommendations for women with prior CVT, including prophylactic low-molecular-weight heparin during pregnancy and for at least six weeks postpartum when there is no contraindication. Decisions about hormonal contraception or future pregnancy should be individualized according to the trigger and recurrence risk.
Look for the cause without assuming there must be one inherited disorder
Potential risk factors include pregnancy and puerperium, estrogen-containing medication, malignancy, infection, inflammatory or autoimmune disease, hematologic disorders and inherited or acquired thrombophilia. Some events remain unprovoked. A useful review distinguishes transient triggers from persistent recurrence risks because that distinction affects anticoagulation duration and future prevention.
Heidelberg has an explicit sinus and cerebral-vein thrombosis treatment pathway
Heidelberg University Hospital's Neuroradiology service states that classic treatment is medication, particularly heparin, and that severe cases can undergo minimally invasive mechanical recanalization. Its dedicated neurovascular consultation and vascular/interventional neuroradiology section make Heidelberg a relevant verified center for complex imaging review, rescue-procedure assessment and post-acute second opinion.
What to send for a German post-acute CVST/CVT second opinion
The center needs enough information to confirm the venous diagnosis, understand severity and determine recurrence risk.
- Initial and follow-up CT/CTV or MRI/MRV DICOM files
- Radiology reports describing the involved sinus and/or cortical veins
- Hospital discharge summary and neurological examination
- Any venous infarction or intracranial haemorrhage imaging
- Medication timeline: heparin, LMWH, DOAC or vitamin-K antagonist, including doses
- Laboratory results including blood count, renal function and any thrombophilia tests already performed
- Pregnancy/postpartum status or estrogen-containing medication at the time of thrombosis when relevant
- Cancer, infection, autoimmune or hematologic history
- Seizure history and antiseizure medication if used
- Follow-up imaging and current symptoms such as headache, visual symptoms or cognitive complaints
- Exact question: confirm CVT, review anticoagulant choice/duration, evaluate recurrence risk, pregnancy counseling, interpret incomplete recanalization or review a prior thrombectomy
New deterioration requires immediate local reassessment
A new severe headache, seizure, focal neurological deficit, visual deterioration, repeated vomiting, reduced consciousness or rapidly worsening symptoms after a known CVT require urgent local emergency reassessment. Do not delay acute treatment while arranging an international second opinion.
Official sources
Sources last checked 2026-09-02. Clinical pathways, eligibility and hospital procedures can change; confirm current requirements directly with the treating center.
- German S2k guideline – cerebral venous and dural sinus thrombosis — AWMF / German Neurological Society ↗
- New recommendations from the German consensus-based S2k guideline — Neurological Research and Practice ↗
- Mechanical recanalization of sinus or cerebral-vein thrombosis — Heidelberg University Hospital ↗